Skip to main content

TriSalus Life Sciences, Inc.

TLSI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001826667

No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.

Other share classesTLSIW

Q4 2025 vs. Q3 2025

How the institutions holding TriSalus Life Sciences, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of TLSI: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders5664+8
Shares9.56M11.4M+1.84M (+19.3%)
Value$44.5M$79.6M+$35.2M (+79.1%)

New holders (14)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to TLSI in Q4 2025
InstitutionSharesValue% of portfolio
Kotler Kevin145,200$1.01M0.75%
Empire Financial Management Company, LLC72,027$502.7K0.11%
Laird Norton Trust Company, LLC34,950$244.0K0.01%
Deutsche Bank AG23,546$164.4K0.00%
MetLife Investment Management18,135$126.6K0.00%
Price T Rowe Associates Inc14,814$104.0K0.00%
Man Group plc14,620$102.0K0.00%
HighMark Wealth Management LLC10,800$75.4K0.03%
Abel Hall, LLC10,500$73.3K0.02%
Invesco Ltd.10,292$71.8K0.00%
Ritter Daniher Financial Advisory LLC500$3.49K0.00%
GAMMA Investing LLC58$4050.00%
Rachor Investment Advisory Services, LLC51$3560.00%
True Wealth Design, LLC1$70.00%

Sold out (6)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of TLSI in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
CI Private Wealth, LLC75,700$352.0K
Vestcor Inc23,376$109.0K
Sequoia Financial Advisors, LLC19,456$90.5K
Wolverine Asset Management LLC820$3.81K
SBI Securities Co., Ltd.2$9
IFP Advisors, Inc1$5